SC 13D

Company

SOLENO THERAPEUTICS INC

Filed

December 27, 2018

Accession Number

0000905718-18-000999

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →